Why did FLNA stock move up on 2026-09-22?
In plain English
No clear news behind the move — this looks driven by momentum rather than a specific catalyst.
What it means for you
Finished the day strong — closed near its highs on heavy volume. Risk level: moderate.
Where this comes from
Observed market data. The price, percentage move, open, close and volume above are end-of-day figures for 2026-09-22 from XNAS, not estimates.
No confirmed catalyst. The news feed returned no article for this ticker around this date. That does not mean nothing happened — only that we found nothing we can source, so we are not going to invent a reason.
About Filana Therapeutics, Inc. Common Stock
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral tr
FLNA — frequently asked
Why did FLNA stock move up on 2026-09-22?
No clear news behind the move — this looks driven by momentum rather than a specific catalyst. Finished the day strong — closed near its highs on heavy volume.
See it in context
FLNA opened +33.2% versus the prior close, then finished +4.6% from its open, on 94.3M shares traded.
Against the whole market that day, 55.9% of US stocks closed higher (median move +0.1%) — so FLNA was moving with a broadly higher market. See the full market recap →
More movers: today's biggest gainers · today's biggest gap-ups · all screeners · why other stocks are moving
Learn the basics: how to read a chart · what volume means · grade FLNA’s chart with the AI reader →